Affiliate links: as an Amazon Associate and through other programs, we earn from qualifying purchases, at no extra cost to you. Learn more.
Quick answer: Ashwagandha should be avoided in pregnancy and while breastfeeding, it has been linked to rare cases of liver injury, and it may change thyroid hormone levels, so talk to your doctor before you take it. Trials done only in women are few and small: five trials of 50 to 100 women, lasting 8 to 12 weeks and mostly using 300 mg of root extract twice a day, looked at menopause symptoms and sexual function. In mixed groups of men and women, its clearest effect is a modest drop in the stress hormone cortisol.
In This Article
Safety First: Who Should Avoid Ashwagandha

Read these points before anything else. They come from two parts of the NIH: the National Center for Complementary and Integrative Health (NCCIH) and the Office of Dietary Supplements (ODS).
Ashwagandha supplements compared: extract and dose (2026)
| Product | On the label | Good to know | Buy |
|---|---|---|---|
| Our pick Nutricost KSM-66 Ashwagandha | 600 mg KSM-66 root extract (min. 5% withanolides) + 5 mg BioPerine per capsule | The extract and the 600 mg daily dose used in several clinical trials. | See it on Amazon ↗ |
| NOW KSM-66 Ashwagandha | 600 mg KSM-66 root extract per capsule | The same extract and dose, without black pepper extract. | See it on Amazon ↗ |
| Life Extension Optimized Ashwagandha | 125 mg Sensoril extract per capsule | A different extract (root and leaf) that is dosed lower, usually 125 to 250 mg a day. | See it on Amazon ↗ |
| Organic India Ashwagandha | 800 mg organic ashwagandha per 2 capsules | No withanolide percentage on the label, so it is not a standardized extract. | See it on Amazon ↗ |
Not for use in pregnancy, and rare cases of liver injury have been reported (NCCIH).
Label figures: NIH Dietary Supplement Label Database and the brand listing, checked October 2026. Formulas change, so check the label before you buy. We earn a commission on Amazon purchases at no extra cost to you, and we do not lab-test products.
- Pregnancy and breastfeeding: ashwagandha should be avoided during pregnancy and should not be used while breastfeeding (NCCIH). Some reports suggest it might cause miscarriage (NIH ODS).
- Liver: although rare, a number of cases have linked liver injury to ashwagandha supplements (NCCIH); some of the people affected already had liver disease (NIH ODS).
- Thyroid: ashwagandha might affect thyroid function. In a small trial in 50 people with subclinical hypothyroidism, 300 mg twice a day for 8 weeks lowered TSH and raised T3 and T4, and three case reports described an overactive thyroid (thyrotoxicosis) in women taking it (NIH ODS). NCCIH does not recommend it for people with thyroid disorders (NCCIH).
- Autoimmune conditions and surgery: NCCIH does not recommend it for people with autoimmune disorders or for people who are about to have surgery (NCCIH).
- Medicines: it might interact with medicines for diabetes and high blood pressure, immunosuppressants, sedatives, anti-seizure medicines and thyroid hormone medicines (NCCIH).
Ashwagandha may be safe when taken for up to 3 months, but there is not enough information to judge longer use (NCCIH). In 2024, the French food safety agency recommended against it for pregnant and breastfeeding women and for people with hormone (endocrine) disorders (NIH ODS).
Get our free supplement cheat sheet.
One page: typical doses, timing and upper limits for ten well-studied supplements. No upsell.
🔒 No spam. Unsubscribe anytime. We send 1-2 emails/month max.
What Trials in Women Found
These are the placebo-controlled trials of ashwagandha alone in women that we found in PubMed. All were small, all lasted 8 to 12 weeks, and all were done in India.
Menopause and perimenopause symptoms
In 100 perimenopausal women with symptoms (91 finished), 300 mg of root extract twice a day for 8 weeks lowered menopause symptom scores and raised estradiol more than placebo; testosterone did not change (Gopal et al., 2021). The abstract does not report who paid for the study.
In 60 women aged 45 to 55, the same dose for 56 days lowered menopause symptom scores, hot flashes and perceived stress more than placebo. The extract came from its maker, and the authors declared no commercial conflicts (Vani et al., 2025).
In 66 postmenopausal women aged 45 to 65 (63 finished), 600 mg a day for 12 weeks improved sleep scores and menopause symptom scores more than placebo, with a small drop in body fat (0.6%); bone density did not change (Obhrai et al., 2026).
These results are promising but thin: three small trials from one country, short follow-up, and no comparison with established menopause treatments. NCCIH, in its 2023 fact sheet, said there was not enough evidence to know whether ashwagandha helps with menopause (NCCIH). For an overview of what helps with menopause, see our menopause supplement guide.
Sexual function
In a pilot trial, 50 women with sexual dysfunction took 300 mg of root extract or placebo twice a day for 8 weeks, and sexual function scores improved more with ashwagandha. The extract maker provided the extract and paid some of the costs (Dongre et al., 2015).
In 80 women aged 18 to 50 with low sexual desire, the same dose for 8 weeks raised a sexual function score from 14.2 to 22.6, versus 14.2 to 19.3 with placebo. The extract came from its maker (Ajgaonkar et al., 2022).
| Trial | Women | Dose and length | Main result | Product or funding |
|---|---|---|---|---|
| Perimenopause symptoms (2021) | 100 (91 finished) | 300 mg twice a day, 8 weeks | Lower symptom scores; higher estradiol | Not reported in the abstract |
| Menopause symptoms (2025) | 60 | 300 mg twice a day, 56 days | Lower symptom scores and fewer hot flashes | Extract from its maker; no conflicts declared |
| Postmenopause sleep and symptoms (2026) | 66 (63 finished) | 600 mg a day, 12 weeks | Better sleep and symptom scores; bone density unchanged | No conflicts reported |
| Sexual function, pilot (2015) | 50 | 300 mg twice a day, 8 weeks | Better sexual function scores | Maker supplied the extract and paid some costs |
| Low sexual desire (2022) | 80 | 300 mg twice a day, 8 weeks | Better sexual function scores | Extract from its maker; no conflicts declared |
Stress, Sleep and Hormones in Trials With Men and Women
Most ashwagandha trials enrolled both men and women. A 2025 meta-analysis of 7 trials found a modest drop in the stress hormone cortisol (1.16 µg/dL on average) but no clear effect on how stressed people felt (Albalawi, 2025).
For sleep, a 2021 meta-analysis of 5 trials (400 adults) found a small benefit that was larger in people with insomnia, at 600 mg a day or more, and after 8 weeks or more (Cheah et al., 2021). NCCIH says some ashwagandha preparations may help with insomnia and stress, while the evidence on anxiety is unclear (NCCIH).
Hormones in women
A 2026 meta-analysis of 23 trials (1,706 people) found that ashwagandha lowered cortisol and slightly raised the thyroid hormone T4. It raised testosterone in men but not in women, and it did not change estradiol in either sex (Fornalik et al., 2026). Two of the menopause trials above did report higher estradiol (Gopal et al., 2021; Vani et al., 2025), so the picture is mixed, and the T4 rise is one more reason for caution if you have a thyroid condition.
Fertility
We found no placebo-controlled trials on pregnancy rates in women taking ashwagandha. NCCIH says there is not enough evidence on female infertility; the limited fertility evidence it describes is in men, for testosterone and sperm quality (NCCIH). If you are trying to conceive, remember that ashwagandha should be avoided once you are pregnant.
If You Decide to Try It
- Talk to your doctor first if you have a thyroid condition, an autoimmune disease or liver problems, or take any of the medicines listed above, and do not take it if you could be pregnant.
- The women’s trials mostly used 300 mg of root extract twice a day (600 mg a day) for 8 weeks (Gopal et al., 2021; Ajgaonkar et al., 2022).
- Keep use to about 3 months unless your doctor agrees to more, because longer-term safety is unknown (NCCIH).
- Choose a product that states the plant part, the amount of extract in mg and the withanolide percentage. The trials above used root extracts standardized for withanolides (Dongre et al., 2015).
- For a full comparison of extracts and doses, see our ashwagandha guide.
Side Effects and What to Watch For
In trials, side effects were usually mild. NCCIH lists drowsiness, stomach upset, diarrhea and vomiting in some people (NCCIH). In the trial of 80 women, two reported nausea and one drowsiness with ashwagandha, a pattern similar to the placebo group (Ajgaonkar et al., 2022).
Stop taking it and contact your doctor if you feel unwell, especially with signs of a liver or thyroid problem.
The Bottom Line
For women, ashwagandha has small, short trials on menopause symptoms and sexual function, and a modest cortisol effect in mixed groups. The safety rules matter more than the benefits: avoid it in pregnancy and while breastfeeding, skip it with thyroid or autoimmune conditions or liver problems, and keep use to about 3 months (NCCIH).
Ashwagandha is one of the better-studied adaptogens. Several trials found a modest drop in cortisol; results for perceived stress are mixed and the testosterone evidence is limited (NIH). Choose an extract tested in trials (KSM-66, Sensoril or Shoden), use it for up to 3 months, and skip it if you have a thyroid or autoimmune condition, liver problems, or are pregnant.
Scientific References
- Gopal et al., 2021. Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study. J Obstet Gynaecol Res.
- Vani et al., 2025. A prospective, randomized, double-blind, placebo-controlled study on efficacy and safety of Ashwagandha root extract (Withania somnifera) for managing menopausal symptoms in women. Front Reprod Health.
- Obhrai et al., 2026. Effects of Withania somnifera root extract on sleep quality, body composition, and menopausal symptoms in postmenopausal women: a randomized, double-blind, placebo-controlled trial. Menopause.
- Dongre et al., 2015. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Improving Sexual Function in Women: A Pilot Study. Biomed Res Int.
- Ajgaonkar et al., 2022. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract for Improvement of Sexual Health in Healthy Women: A Prospective, Randomized, Placebo-Controlled Study. Cureus.
- Albalawi, 2025. Dual impact of Ashwagandha: Significant cortisol reduction but no effects on perceived stress – A systematic review and meta-analysis. Nutr Health.
- Cheah et al., 2021. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. PLoS One.
- Fornalik et al., 2026. Hormonal Modulation with Withania somnifera: Systematic Review and Meta-Analysis of Randomized-controlled Trials. Planta Med.
- NCCIH: Ashwagandha, Usefulness and Safety (updated March 2023).
- NIH Office of Dietary Supplements: Ashwagandha, Health Professional Fact Sheet (updated May 2, 2025).



